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ROSWilson disease (WD) is caused by mutations of the WD gene ATP7B resulting in copper accumulation in dif-
ferent tissues. WD patients display hepatic and neurological disease with yet poorly understood pathome-
chanisms. Therefore, we studied age-dependent (3, 6, 47 weeks) biochemical and bioenergetical changes
in Atp7b−/− mice focusing on liver and brain. Mutant mice showed strongly elevated copper and iron levels.
Age-dependently decreasing hepatic reduced glutathione levels along with increasing oxidized to reduced
glutathione ratios in liver and brain of 47 weeks old mice as well as elevated hepatic and cerebral superoxide
dismutase activities in 3 weeks old mutant mice highlighted oxidative stress in the investigated tissues. We
could not ﬁnd evidence that amino acid metabolism or beta-oxidation is impaired by deﬁciency of
ATP7B. In contrast, sterol metabolism was severely dysregulated. In brains of 3 week old mice cholesterol,
8-dehydrocholesterol, desmosterol, 7-dehydrocholesterol, and lathosterol were all highly increased. These
changes reversed age-dependently resulting in reduced levels of all previously increased sterol metabolites
in 47 weeks old mice. A similar pattern of sterol metabolite changes was found in hepatic tissue, though
less pronounced. Moreover, mitochondrial energy production was severely affected. Respiratory chain com-
plex I activity was increased in liver and brain of mutant mice, whereas complex II, III, and IV activities were
reduced. In addition, aconitase activity was diminished in brains of Atp7b−/− mice. Summarizing, our study
reveals oxidative stress along with severe dysfunction of mitochondrial energy production and of sterol me-
tabolism in Atp7b−/− mice shedding new light on the pathogenesis of WD.C, 8-Dehydrocholesterol; ESI-
etry; Nitroso-PSAP, 2-Nitroso-
oxygen species; SOD, Super-
l, Department of General Pediat-
er Feld 430,D-69120Heidelberg,
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Wilson disease (WD) is an autosomal recessive disorder caused by
mutations of the WD gene ATP7B encoding for a copper transporting
P-type ATPase [1]. Due to the deﬁcient transporter copper excretion
into the bile is impaired and it accumulates in liver and other organs,
e.g. the brain, resulting in progressive clinical manifestations [2].
WD patients may suffer from liver disease, neurological or psychiatric
abnormalities, or various combinations of these symptoms [3,4].The mechanisms underlying the pathophysiology of WD are not
well understood. Established animal models for WD are the Long
Evans Cinnamon rat [5], the toxic milk mouse [6], and the Atp7b−/−
mouse [7–9], all showing hepatic copper accumulation. However, ce-
rebral damage has not yet been described in these animal models.
With regard to the liver it has been proposed that free radical gener-
ation by excess copper and subsequent oxidative changes of organel-
lar lipids and thiol-containing proteins in hepatocytes accounts for
the development and progression of liver damage [10–12]. In line
with this notion chronic copper exposure dramatically altered pro-
teins involved in anti-oxidant defense in HepG2 cells [13,14]. A
study of Gu and colleagues [15] in liver samples from affected pa-
tients indicated severe dysfunction of enzymes of mitochondrial en-
ergy production. Whether this was cause or consequence of liver
damage remained unclear. Recently, a study in Atp7b−/− mice indi-
cated imbalance of cholesterol metabolism [16].
To enhance the pathophysiological understanding of WDwe stud-
ied the biochemical and bioenergetical phenotype of Atp7b−/− mice.
As marker for oxidative stress Mn-dependent and Cu/Zn-dependent
1608 S.W. Sauer et al. / Biochimica et Biophysica Acta 1812 (2011) 1607–1615superoxide dismutase as well as glutathione content was measured.
For biochemical characterization amino acid and acylcarnitine proﬁle
as well as metabolites of cholesterol biosynthesis were analyzed. To
study the bioenergetical phenotype of Atp7b−/− mice, we measured
enzyme complexes of the respiratory chain and aconitase.2. Materials and methods
2.1. Animals
The generation of Atp7b−/−mice has been described previously [7].
Atp7b−/− mice (with a genetic 129/Sv background) and wild type
129/Sv mice were housed at the University of Heidelberg according to
the guidelines of the Institutional Animal Care and Use Committees
and in accordance with governmental requirements. Atp7b−/− and
wild typemice at ages of 3, 6 weeks and 47 weeks were used for the ex-
periments (7 animals per group). Mice were kept on a 12 h:12 h light:
dark cycle. Food (normal chow diet containing 176 μg/g iron and
16 μg/g copper) and water were provided ad libitum. Animals were
anesthetized with ketamine/xylazine. Blood was collected by cardiac
puncture under anesthesia and afterwards animals were systematically
perfusedwith saline from the left ventricle after thoracotomy to remove
whole blood fromorgans. Subsequently tissueswere removed and sam-
ples were stored at−80 °C.2.2. Preparation of tissue homogenates
Tissues (brain and liver) were homogenized with a Potter Elvehjem
system in a buffer containing 250 mmol/L sucrose, 50 mmol/L KCl,
5 mmol/L MgCl2, 20 mmol/L Tris/HCl (adjusted at pH 7.4). Protein wasFig. 1. Hepatic and cerebral iron and copper contents. Atp7b−/− mice displayed elevated hep
creased and iron levels (B) were elevated in 3 and 47 week old mice. Cerebral copper con
mice. Data are expressed as mean±SD in μg/g wet weight (n=7 mice per group; * pb0.05determined according to Lowry [17] with themodiﬁcations of Helenius
and Simons [18] using bovine serum albumin as a standard.
2.3. Measurement of iron-metabolism parameters
Tissue iron and copper quantiﬁcation using atomic absorption
spectroscopy was performed as described previously [19]. Iron and
copper concentrations of tissues (μg/g of wet tissue) were calculated
from the results of this analysis. The Ferrozinmethodwas employed to
quantify serum iron levels (AU 640, Olympus Diagnostics, Hamburg,
Germany). In acidic environment, binding of reduced iron to [2,4,6-Tri-
(2-Pyridyl)-5-Triazin] results in a blue colored complex, which is mea-
sured in a dual wavelength mode (600–800 nm).
2.4. Cu/Zn- and Mn-dependent superoxide dismutase
Cu/Zn- and Mn-dependent superoxide dismutase (SOD) activities
were determined using a SOD assay kit (Cayman Chemical, Ann
Arbor, U.S.A.) according to the manufacturer's protocol. In brief, tissue
homogenates were centrifuged for 10 min at 600×g and 4 °C. The su-
pernatantwas centrifuged for 10 min at 3.500×g and 4 °C. The resulting
cytosolic and mitochondrial fractions were used to assay Cu/Zn- and
Mn-SOD respectively. Themitochondrial pellet was sonicated to disrupt
membranes. To further differentiate between cytosolic and mitochon-
drial SOD, Cu/Zn- and Mn-SOD was inhibited by the addition of 3 mM
potassium cyanide.
2.5. Glutathione content
Glutathione contents were assayed in tissue homogenates as pre-
viously described [20] with modiﬁcations. Tissue homogenates wereatic copper and, in addition, iron levels. In liver copper levels (A) age-dependently in-
tents (C) were elevated in 47 week old mice and iron levels (D) in 6 and 47 week old
).
Fig. 2. Activities of Cu/Zn- and Mn-dependent SOD. Cu/Zn- and Mn-dependent SOD were assayed in liver (A) and brain (B) tissue homogenates of Atp7b−/− and wild type mice. Hepatic
activity of both enzymes was increased in 3 week old mutant mice. In liver of older mice and in brain of all age groups activities were unchanged compared to wildtype mice. Data are
expressed as mean±SD in mU/g protein (n=7 mice per group;* pb0.05).
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deproteinized by addition of 0.5 volumes of sulfosalicylic acid (5%)
and incubated for 30 min on ice. Afterwards, the samples centrifuged
for 10 min at 1000*g and 4 °C. The pH of supernatants was increased
by the addition of 50 μL triethanolamine (4 M) per mL sample. To
measure GSH/GSSG ratio one part of the samples was derivatized with
10 μL 2-vinlypyridine (1 M) per mL of sample. GSH and GSSG content
was detected as absorbance change at 410 nm that was correlated to a
calibration curve and normalized to the protein content.2.6. Quantitative analysis of acylcarnitines and amino acids
Acylcarnitines and amino acids were determined in tissue homog-
enates by electrospray ionization tandem mass spectrometry (ESI-
MS/MS) according to a modiﬁed method as previously described
[21] using a Quattro Ultima triple quadrupole mass spectrometer
(Micromass, Manchester, UK) equipped with an electrospray ion
source and a Micromass MassLynx data system.2.7. Sterol analysis in tissue samples
After preparation of liver and brain homogenates and protein deter-
mination a sample of 1 mg total protein dissolved in 1 mlwaterwas hy-
drolyzed and extracted as previously described [22]. Subsequentdifferentiation and quantiﬁcation of sterols were performed by gas
chromatography/mass spectrometry [23].
2.8. Spectrophotometric analysis of single respiratory chain complexes
I–V and aconitase
Steady state activities of respiratory chain complexes I–V and aco-
nitase in tissue homogenates were recorded using a computer tunable
spectrophotometer (Spectramax Plus Microplate Reader, Molecular
Devices, Sunnyvale, California, U.S.A.) operating in the dual wave-
length mode. Samples were analyzed in temperature-controlled
96-well plates in a ﬁnal volume of 300 μL as previously described
[20]. In brief, tissue homogenates were centrifuged for 10 min at
600×g and 4 °C. The resulting supernatant was centrifuged for 10 min
at 3.500×g and 4 °C. Themitochondrial pellet was used for further enzy-
matic assays. The speciﬁcity of the enzymatic assays was validated by the
addition of standard respiratory chain inhibitors (complex I: 2-
n-decylquinazolin-4-yl-amine [1 μmol/L]; complex II: thenoyltriﬂuoroa-
cetone [8 mmol/L]; complex III: antimycin A [1 μmol/L]; complex IV:
NaCN [2 mmol/L]; complex V: oligomycin [80 μmol/L]).
2.9. Statistical analysis
Data are expressed as mean±S.D. if not noted otherwise. For pair
wise and multiple comparisons Mann Whitney U test and Kruskal–
Fig. 3. Glutathione content. Cerebral glutathione content was not signiﬁcantly changed in Atp7b−/− mice, whereas hepatic levels were signiﬁcantly increased in 3 week old mutant
mice. Hepatic glutathione levels were constantly decreasing over the age in mutant mice (A). In addition, oxidized to reduced glutathione (GSSG/GSH) ratios were highly elevated
in liver and brain of 47 week old mice (B). Data are expressed as mean±SD in nmol/mg protein (n=7 mice per group;* pb0.05).
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Time-dependent changes were evaluated using ANOVA repeated mea-
sures. All statistics were calculated in SPSS for Windows 16.0 Software.
pb0.05 was considered as signiﬁcant.
3. Results
3.1. Elevated copper and iron levels in brain and liver
First we studied copper and iron content in liver and brain of
Atp7b−/−mice.Mutantmice displayed strongly elevated hepatic copper
and, in addition, iron levels. Copper levels age-dependently increased,
whereas iron content was elevated in 3 and 47 week old mice. Copper
levels in brain tissue were increased but only in 47 week old mice.
Strikingly, the increase of cerebral iron content already occurred in
6 week old mice (Fig. 1).
3.2. Altered oxidative stress response
To evaluate oxidative stress in Atp7b−/−mice, we determined glu-
tathione concentrations and SOD activity in liver and brain homoge-
nates. Cu/Zn-dependent and Mn-dependent SOD activities were
highly induced in the liver of 3 week old mutant mice, whereasunchanged in liver tissue of 6 week or 47 week old mice. Cerebral ac-
tivities of both enzymes were similar in wild type and Atp7b−/−mice
of all age groups (Fig. 2). Cerebral glutathione content did not differ
between brain homogenates of mutant and wild type mice. In con-
trast, hepatic glutathione levels of 3 week old mutant mice were
higher than in age-matched wild type mice. Further, glutathione
levels were decreasing in mutant mice over the age, whereas similar
glutathione concentrations were found in wild type mice of all age
groups (Fig. 3A). Moreover, 47 week old mice showed highly in-
creased oxidized to reduced glutathione (GSSG/GSH) ratios in liver
and brain (Fig. 3B).3.3. Increase of alanine content as marker of oxidative stress
Next, we studied whether amino acid metabolism was affected in
mutant mice determining amino acid concentrations in liver and
brain tissue as well as in serum of mutant and wild type mice.
3 week oldmutantmice showed reduced concentrations of L-alanine
in liver tissue, whereas 6 and 47 week old mutant mice displayed in-
creased hepatic levels. Noteworthy, L-alanine is a marker for mito-
chondrial dysfunction [24]. Other amino acids were unchanged in
mutant mice (Table 1).
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Acylcarnitine proﬁling is a well established method to study beta-
oxidation defects. Changes in the proﬁle are like ﬁngerprints for enzy-
matic defects in themitochondrial fatty acid degradation. Free carnitine
levels in liver and acetylcarnitine concentrations in serum were re-
duced in mutant mice of all tested age groups. Beside these ﬁndings,
no major changes of beta-oxidation metabolites were found in liver,
brain or serum of mutant mice suggesting unaffected beta-oxidation
(Table 2).
3.5. Complex pattern of sterol metabolism dysregulation
A recent study indicated that Atp7b−/− mice display a disturbed
cholesterol metabolism. Therefore, we measured different sterols in
liver, brain, and serum of mutant compared to wild type mice. In
brain homogenates several sterol metabolites revealed an intriguing
pattern of concentration changes, in 3 week old mice cholesterol,
8-DHC, desmosterol, 7-DHC, and lathosterol were highly increased
ranging from 1.6 to 4.7 fold. The high brain levels of these metabolites
were decreasing in an age dependent way resulting in reduced cho-
lesterol, desmosterol, and lathosterol concentrations in 6 week old
mice and highly reduced levels of all previously increased sterol me-
tabolites in 47 week old mice. The hepatic phenotype was less severe.
Although the concentrations of all tested sterol metabolites were
lower or decreasing over the age, only cholesterol was signiﬁcantly
reduced in 3 and 6 week old mice. In serum, cholesterol, cholestanol,
8-DHC, 7-DHC, and desmosterol were reduced in 47 week old mice
(Fig. 4).
3.6. Impairment of mitochondrial energy metabolism
Oxidative damage induced by Fenton reaction is thought to play
a major role in the pathophysiology of WD. The respiratory chain is
a major source of ROS but also especially susceptible to oxidative
damage. Therefore, we investigated the activity of respiratory chain sin-
gle enzyme complexes in liver and brain homogenates. Strikingly, there
was a time-dependent increase of complex I activity in liver and brain
tissue. Complex II activity was reduced in the liver of 47 week old mice
and in brain tissue independent of age. Hepatic complex III activity
was decreased and complex IV activity was lower in liver and brain ho-
mogenates of 47 week oldmutantmice. Complex V displayed a reduced
activity in liver and brain of 3 and 6 week old mutantmice, 47 week old
mice however were indistinguishable from wild type mice. Comparing
only genotypes, Atp7b−/− mice display a common phenotype in liver
and brain consisting of increased complex I and reduced complex III-V
activities except for complex II which was only reduced in brain tissue
(Fig. 5).
Aconitase is highly vulnerable for oxidative stress. Therefore, we
analyzed aconitase activity in tissue homogenates. Hepatic activity
was unchanged in mutant mice, whereas cerebral activity was lower
in 3 and 6 week old Atp7b−/−mice compared to their wild type litter-
mates (Fig. 6).
4. Discussion
WD patients display progressive hepatic and cerebral disease. The
main biochemical ﬁnding is massive copper accumulation in affected
tissue. The underlying pathomechanism of tissue damage, however,
remains unknown. Copper accumulation has been suggested to induce
ROS production by Fenton reaction leading to oxidative damage of pro-
teins and lipids. Tounravel thepathomechanismofWD,webiochemically
and bioenergetically characterized Atp7b−/− mice. Corresponding to af-
fected human individuals Atp7b−/−mice display highly elevated copper
and, in addition, iron levels in liver and brain.We could show that hepatic
GSH levels age-dependently decreased, whereas oxidized to reduced
Table 2
Acylcarnintine contents in liver, brain and serum of wild type and mutant mice C0, free carnitine; C2, acetylcarnitine; C3, propionylcarnitine; C4, butyrylcarnitine; C5:1, pentenoylcar-
nitine; C5, isovalerylcarnitine; C6, hexanoylcarnitine; C8:1, octenoylcarnitine; C8, octanoylcarnitine; C10:1, decenoylcarnitine; C10, decanoylcarnitine; C12, dodecanoylcarnitine;
C14:1, tetradecenoylcarnitine; C14, tetradecanoylcarnitine; C14OH, hydroxytetradecanoylcarnitine; C16:1, hexadecenoylcarnitine; C16, palmitoylcarnitine; C16:1OH, hydroxyhex-
adecenoylcarnitine; C16OH, hydroxyhexadecanoylcarnitine; C18:1, octadecenoylcarnitine; C18, stearoylcarnitine; C18:1OH, hydroxyoctadecenoylcarnitine; C18OH, hydroxyocta-
decanoylcarnitine; C18:2, octadecadienoylcarnitine. Data are presented as mean in nmol/mg protein (liver, brain) or μM (serum; n=7 mice per group;* pb0.05).
Liver Brain Serum
Weeks
of age
Wild type Mutant Wild type Mutant Wild type Mutant
3 6 47 3 6 47 3 6 47 3 6 47 3 6 47 3 6 47
C0 46.56 44.08 44.39 26.93 25.70 30.29 79.33 90.33 72.74 68.93 64.15 77.59 18.17 16.09 17.45 12.17* 12.25* 13.14*
C2 50.98 47.91 45.12 48.65 50.14 43.21 2.61 5.10 8.66 2.31 2.18 10.31 6.67 5.85 5.59 3.89* 2.99* 2.91*
C3 0.30 0.26 0.21 0.24 0.23 0.14 0.44 0.37 0.22 0.26 0.24 0.16 0.19 0.09 0.27 0.13 0.09 0.08
C4 0.30 0.21 0.20 0.18 0.16 0.23 3.73 4.28 4.23 1.81 4.37 4.43 0.71 0.17 0.29 0.67 0.14 0.11
C5:1 0.15 0.24 0.30 0.09 0.13 0.33 0.06 0.16 0.08 0.08 0.05 0.06 0.03 0.01 0.01 0.01 0.01 0.01
C5 0.57 0.46 0.39 0.31 0.32 0.62 0.25 0.28 0.21 0.42 0.22 0.30 0.18 0.09 0.14 0.11 0.09 0.06
C6 0.13 0.10 0.19 0.08 0.16 0.08 0.09 0.11 0.05 0.09 0.08 0.05 0.08 0.03 0.02 0.05 0.02 0.01
C8:1 1.14 1.31 1.20 1.41 0.96 1.11 0.48 0.29 0.17 0.64 0.32 0.17 0.03 0.01 0.01 0.01 0.01 0.01
C8 0.04 0.07 0.06 0.00 0.05 0.00 0.04 0.05 0.15 0.07 0.08 0.04 0.04 0.01 0.01 0.02 0.01 0.01
C10:1 0.29 0.42 0.28 0.51 0.27 0.46 0.10 0.10 0.08 0.14 0.06 0.08 0.09 0.04 0.03 0.03 0.03 0.03
C10 0.05 0.09 0.05 0.13 0.14 0.07 0.06 0.08 0.09 0.07 0.07 0.03 0.10 0.03 0.02 0.03 0.02 0.02
C12 0.05 0.02 0.00 0.21 0.00 0.03 0.02 0.00 0.00 0.03 0.08 0.05 0.19 0.03 0.01 0.01 0.01 0.01
C14:1 0.09 0.11 0.05 0.09 0.06 0.05 0.08 0.04 0.03 0.07 0.09 0.04 0.02 0.05 0.02 0.01 0.02 0.02
C14 0.11 0.39 0.15 0.14 0.17 0.19 0.28 0.23 0.09 0.22 0.15 0.10 0.16 0.07 0.03 0.04 0.03 0.03
C14OH 0.20 0.23 0.19 0.28 0.24 0.14 0.32 0.16 0.14 0.22 0.13 0.11 0.13 0.02 0.02 0.01 0.01 0.01
C16:1 0.09 0.09 0.08 0.10 0.07 0.06 0.09 0.05 0.05 0.06 0.04 0.03 0.02 0.03 0.02 0.01 0.02 0.01
C16 0.19 0.26 0.33 0.25 0.31 0.22 0.11 0.18 0.17 0.11 0.11 0.09 0.12 0.16 0.08 0.08 0.10 0.07
C16:1OH 0.17 0.19 0.25 0.20 0.38 0.25 0.12 0.11 0.04 0.16 0.07 0.05 0.01 0.01 0.01 0.01 0.01 0.01
C16OH 0.47 0.46 0.47 0.60 0.51 0.34 0.14 0.15 0.12 0.19 0.10 0.10 0.01 0.02 0.01 0.01 0.01 0.01
C18:1 0.08 0.07 0.18 0.14 0.10 0.09 0.12 0.10 0.08 0.08 0.07 0.04 0.04 0.06 0.04 0.03 0.04 0.03
C18 0.28 0.26 0.29 0.34 0.20 0.23 0.16 0.15 0.09 0.13 0.11 0.10 0.06 0.05 0.03 0.04 0.04 0.03
C18:1OH 0.20 0.17 0.21 0.14 0.11 0.07 0.05 0.06 0.07 0.07 0.04 0.05 0.01 0.01 0.01 0.01 0.01 0.01
C18OH 0.33 0.42 0.40 0.47 0.26 0.32 0.15 0.20 0.08 0.22 0.12 0.11 0.02 0.01 0.01 0.01 0.01 0.01
C18:2 0.08 0.12 0.09 0.07 0.09 0.10 0.05 0.09 0.08 0.06 0.06 0.04 0.03 0.05 0.03 0.03 0.03 0.02
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ther, superoxide dismutase activities in liver and brain of 3 week oldmu-
tant mice were up-regulated. Both ﬁndings clearly indicate production of
ROS and altered anti-oxidative response. Mitochondrial respiratory chain
is awell-known source and target of ROS. Accordingly,mitochondrial dys-
function and morphological abnormalities were described in liver from
patientswithWD [15,25]. Oxidative damagewas found in liver ofWDpa-
tients and in two rat models forWD, namely copper-loaded rats [26] and
the Long-Evans Cinnamon rat model [27]. Noteworthy, the study of Gu
and colleagues [15] provided evidence for decreased activities of respi-
ratory chain complexes I–IV as well as of aconitase in liver tissue from 3
affected patients with deteriorating liver function and hepatic failure.
The authors speculated that these changesmay be induced either by di-
rect oxidative damage of proteins or by depletion of mtDNA due to ROS.
In such an advanced state of liver failure, however, it remains unclear
whether respiratory chain dysfunction is a cause or consequence of
degenerating hepatocytes. Furthermore, reduced complex II activity
cannot be explained by mtDNA depletion since this protein is entirely
nuclear-encoded. In line with the study of Gu and colleagues, Atp7b−/−
mice display severe and age-dependent dysfunction of respiratory
chain complexes in liver tissue. Since these mice do not develop hepatic
failure, our data indicate that respiratory chain dysfunction is a direct
consequence of Atp7 deﬁciency and contributes to the pathomechanism
of WD. In contrast, complex I activity was age-dependently increased in
mutant mice. This may represent a compensatory mechanism counter-
acting reduced respiratory chain function. Complex I is a major source
of mitochondrial ROS production [28]. Its upregulation will induce in-
creased production of ubiquinol that cannot fully be recycled due to di-
minished complex III activity ultimately leading to ROS production by
reversed electron ﬂow.
Neurological disease in WD is poorly understood, though severe
damage of basal ganglia has been described [29]. Unfortunately, all
available rodent models for WD do not display neurological disease.Interestingly, we could ﬁnd changed cerebral activities of respirato-
ry chain enzyme complexes similar to the liver phenotype and, in
addition, a decrease of aconitase activity. Degeneration of basal gang-
lia is a common ﬁnding in inherited defects of mitochondrial energy
production. Our ﬁndings could therefore point to an involvement of im-
paired respiratory chain function in the neuropathogenesis of WD.
In line with our ﬁndings Zischka and colleagues [30] showed in a
rat model of WD that copper overload changes mitochondrial mem-
brane integrity resulting in structural and functional impairment of
mitochondria. Direct impairment of mitochondrial function by copper
may represent an additional or alternative explanation to oxidative
damage caused by Fenton reaction for the pathophysiology of WD.
A study of Huster and colleagues [16] showed reduced levels of
cholesterol in serum of Atp7b−/− mice. mRNA levels of almost all
proteins involved in cholesterol biosynthesis were down-regulated.
However, sterol regulatory-binding protein 2 (SREBP-2), a tran-
scription factor which activates cholesterol biosynthesis, was acti-
vated and correctly localized. The amount of mRNA for low density
lipoprotein receptor (LDLR), which is directly controlled by SREBP-
2 and would be expected to be up-regulated in response to elevated
SREBP-2 was signiﬁcantly reduced in Atp7b−/− mice and in human
WD livers. Consequently, the authors speculated that SREBP-2 target
genes but not SREBP-2 are dysregulatedmost likely due to an inhibition
of SREBP-2 function by massive copper accumulation. Interestingly ex-
posure of human macrophages to slightly elevated copper concentra-
tions resulted in an increased expression of cholesterol biosynthesis
genes [31]. Long-Evans Cinnamon rats display a similar biochemical
phenotype including reduced cholesterol levels and a reduced activity
of enzymes of sterol metabolism, namely 3-hydroxy-3-methylglutaryl
coenzyme A reductase, cholesterol 7-alpha-hydroxylase, and acyl CoA:
cholesterol acyltransferase [32]. In linewith these studies, we found tre-
mendous changes in sterol metabolism in tissues of Atp7b−/− mice. In
liver samples cholesterol precursors 7-DHC, 8-DHC, lathosterol and
Fig. 4. Sterol metabolism dysregulation. We measured different sterol metabolites in liver (A), brain (B), and serum (C) of mutant and wild type mice. In brain of 3 week old mice
cholesterol, 8-DHC, desmosterol, 7-DHC, and lathosterol were highly increased, whereas cholesterol, desmosterol, and lathosterol concentrations were reduced in 6 week and
47 week old mice. Hepatic cholesterol was also signiﬁcantly reduced in 3 and 6 week old mice. In serum, cholesterol, 8-DHC, 7-DHC, and desmosterol were reduced in 47 week
old mice. Data are presented as mean±SD expressed as concentration in percent of the corresponding wild type littermates (n=7 mice per group;* pb0.05).
1613S.W. Sauer et al. / Biochimica et Biophysica Acta 1812 (2011) 1607–1615lanosterol were elevated in 3 week oldmice. Cholesterol and all precur-
sors decreasedwith age andwere lower than in controls after 47 weeks
of age. In brain of 3 week old mice all sterols were increased compared
to controls. In 6 week old mice cerebral sterols declined with stillmoderate elevations of 7-DHC, 8-DHC and lanosterol. In 47 week old
mice, who have clearly increased cerebral copper concentrations all ste-
rols were signiﬁcantly lower than in controls. These patterns may re-
ﬂect signiﬁcant difference in regulatory cell response to short-term
Fig. 5. Activities of respiratory chain complexes. We studied activities of respiratory chain single enzyme complexes in liver (A) and brain (B) homogenates. Complex I activity was
increasing over the age in liver and brain tissue. In contrast, complex II activity was reduced in the liver of 47 week old mice and in brain tissue of all age groups. Complex III activity
was decreased in the liver and complex IV activity was reduced in liver and brain homogenate of 47 week old mutant mice. Cerebral and hepatic complex V activity was diminished
in liver and brain of 3 and 6 week old mutant mice. Data are presented as mean±SD expressed as activity in percent of the corresponding wild type littermates (n=7 mice per
group;* pb0.05).
1614 S.W. Sauer et al. / Biochimica et Biophysica Acta 1812 (2011) 1607–1615mild copper elevation compared to prolonged exposure to toxic levels
of copper.
Summarizing, Atp7b−/− mice display a pattern of oxidative stress
along with severe dysfunction of mitochondrial energy production
and of sterol metabolism. We hypothesize that these impairments
cause liver disease and neurological abnormalities observed in WD.
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